Responses
Therapeutics
Randomised controlled trial
Fenofibrate and statin therapy, compared with placebo and statin, slows the development of retinopathy in type 2 diabetes patients of 10 years duration: the ACCORD study
Compose a Response to This Article
Other responses
No responses have been published for this article.